- Home
- ARGX vs SYY Comparison
ARGX vs SYY Comparison
Compare ARGX & SYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- SYY
- Stock Information
- Founded
- ARGX 2008
- SYY 1969
- Country
- ARGX Netherlands
- SYY United States
- Employees
- ARGX N/A
- SYY N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- SYY Food Distributors
- Sector
- ARGX Health Care
- SYY Consumer Discretionary
- Exchange
- ARGX Nasdaq
- SYY Nasdaq
- Market Cap
- ARGX 37.3B
- SYY 38.0B
- IPO Year
- ARGX 2017
- SYY N/A
- Fundamental
- Price
- ARGX $640.52
- SYY $73.07
- Analyst Decision
- ARGX Strong Buy
- SYY Strong Buy
- Analyst Count
- ARGX 20
- SYY 14
- Target Price
- ARGX $653.11
- SYY $85.71
- AVG Volume (30 Days)
- ARGX 258.1K
- SYY 2.4M
- Earning Date
- ARGX 02-27-2025
- SYY 01-28-2025
- Dividend Yield
- ARGX N/A
- SYY 2.79%
- EPS Growth
- ARGX N/A
- SYY 9.58
- EPS
- ARGX N/A
- SYY 3.89
- Revenue
- ARGX $1,908,659,000.00
- SYY $79,708,000,000.00
- Revenue This Year
- ARGX $70.98
- SYY $5.32
- Revenue Next Year
- ARGX $51.22
- SYY $4.28
- P/E Ratio
- ARGX N/A
- SYY $18.79
- Revenue Growth
- ARGX 85.56
- SYY 3.76
- 52 Week Low
- ARGX $349.86
- SYY $69.03
- 52 Week High
- ARGX $678.21
- SYY $82.89
- Technical
- Relative Strength Index (RSI)
- ARGX 52.90
- SYY 30.32
- Support Level
- ARGX $657.10
- SYY $72.62
- Resistance Level
- ARGX $678.21
- SYY $75.06
- Average True Range (ATR)
- ARGX 15.00
- SYY 1.15
- MACD
- ARGX 0.45
- SYY -0.27
- Stochastic Oscillator
- ARGX 42.20
- SYY 9.09
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About SYY Sysco Corporation
Sysco is the largest US foodservice distributor with 17% share of the highly fragmented $370 billion domestic market. It distributes roughly 500,000 food and nonfood products to restaurants (62% of fiscal 2024 revenue), education and government buildings (7%), travel and leisure (6%), healthcare facilities (7%), and other locations (18%) where individuals consume away-from-home meals. In fiscal 2024, 70% of the firm's revenue was derived from its US foodservice operations, while its international (18%), quick-service logistics (10%), and other (2%) segments contributed the rest.